Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$40.46 - $43.52 $20.2 Million - $21.8 Million
-500,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $2.76 Million - $2.99 Million
70,000 Added 16.28%
500,000 $0
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $4.63 Million - $5.12 Million
120,000 Added 38.71%
430,000 $18 Million
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $21 Million - $23.7 Million
-555,000 Reduced 64.16%
310,000 $11.8 Million
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $3.98 Million - $4.27 Million
100,000 Added 13.07%
865,000 $34.7 Million
Q2 2018

Aug 13, 2018

BUY
$39.61 - $42.76 $10.5 Million - $11.3 Million
265,000 Added 53.0%
765,000 $30.8 Million
Q1 2018

May 10, 2018

BUY
$36.18 - $40.15 $1.81 Million - $2.01 Million
50,000 Added 11.11%
500,000 $19.5 Million
Q3 2017

Nov 09, 2017

BUY
$39.44 - $41.55 $17.7 Million - $18.7 Million
450,000
450,000 $18.3 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.